Researchers in Germany conducted a study to see if a catheter-based device that closes off a small pouch in the heart called the left atrial appendage could prevent strokes as well as standard medical care. The study involved 912 adults with atrial fibrillation who were at high risk for both stroke and bleeding. Standard medical care included blood-thinning medications when appropriate.
Patients were randomly assigned to receive either the closure device or to continue with physician-directed medical therapy. The main goal was to see if the device was not worse than medication for preventing a combination of serious events, including stroke, major bleeding, or death from heart-related causes. After a median follow-up of three years, the device did not meet the study's standard to be considered as effective as medical therapy. More patients in the device group experienced one of these serious events compared to the medication group.
The study also reported that serious adverse events were common in both groups, but slightly more frequent in the device group. This was a single, well-conducted trial, but its results do not support using this device as a routine alternative to proven medical therapy for these high-risk patients. People with atrial fibrillation should discuss all stroke prevention options with their doctor, as this study suggests current medical management remains a very important approach.